Phosphatidylinositol
|
Basic information |
| Metabolite name | Phosphatidylinositol |
 | N/A |
 |
C01194 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Phosphatidylinositol |
| N/A |
|
C01194 |
|
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between Phosphatidylinositol and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1077 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M673 | Type1 | CUS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M673 | Type1 | CUS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M673 | Type2 | CUS + rTMS group vs. CUS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M673 | Type2 | CUS + fluoxetine group vs. CUS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M673 | Type2 | CUS + rTMS group vs. CUS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M823 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M970 | Type1 | MDD group vs. control group | Plasma | Human | Up |